Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:12 pm Sale | 2024-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | Venrock Healthcare Capital Partners III L.P. | 2,629,786 2.900% | -2,925,769 (-52.66%) | Filing |
| 2024-04-01 6:21 pm Purchase | 2024-03-22 | 13G | Aquestive Therapeutics, Inc. AQST | Venrock Healthcare Capital Partners III L.P. | 5,555,555 6.500% | 5,555,555 (New Position) | Filing |